Trials / Completed
CompletedNCT02536209
A Study to Investigate the Pharmacodynamic Effect of Single Doses of MT-8554 in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the pharmacodynamic effect of single doses of MT-8554 in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-8554 low dose | |
| DRUG | MT-8554 high dose | |
| DRUG | Oxycodone hydrochloride | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-08-31
- Last updated
- 2025-12-22
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02536209. Inclusion in this directory is not an endorsement.